Clinical Trial Update: Use of Sodium Stibogluconate as a Treatment for Leishmaniasis [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/Phase 2 clinical trial evaluating sodium stibogluconate as a treatment for leishmaniasis, with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis

Drugs mentioned

• Sodium stibogluconate (sodium stibogluconate)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Leishmaniasis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-02-27